ALX Oncology
ALXO
ALXO
61 hedge funds and large institutions have $12.6M invested in ALX Oncology in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 32 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less capital invested
Capital invested by funds: $22.1M → $12.6M (-$9.55M)
71% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 34
72% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 32
Holders
61
Holding in Top 10
1
Calls
$48K
Puts
$7K
Top Buyers
| 1 | +$598K | |
| 2 | +$103K | |
| 3 | +$41K | |
| 4 |
Renaissance Technologies
New York
|
+$35.9K |
| 5 |
Squarepoint
New York
|
+$29.4K |
Top Sellers
| 1 | -$806K | |
| 2 | -$343K | |
| 3 | -$300K | |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$255K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$230K |